Clinical Trial: A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214766) titled 'A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants' on Oct. 06.

Brief Summary: This two-part study will evaluate the bioequivalence, safety, and tolerability of a single SC dose of trastuzumab administered via handheld syringe/syringe pump (HHS/SP) with infusion set (IS) and an on-body delivery system (OBDS).

Study Start Date: Oct. 17

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Trastuzumab

Trastuzumab will be administered to participants as a solution for injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: G...